SAF-Holland SE (LON:0O4N)
15.90
-0.96 (-5.69%)
At close: Aug 22, 2025
SAF-Holland SE Revenue
SAF-Holland SE had revenue of 417.24M EUR in the quarter ending September 30, 2025, a decrease of -5.16%. This brings the company's revenue in the last twelve months to 1.73B, down -12.01% year-over-year. In the year 2024, SAF-Holland SE had annual revenue of 1.88B, down -10.89%.
Revenue (ttm)
1.73B EUR
Revenue Growth
-12.01%
P/S Ratio
0.39
Revenue / Employee
351.18K EUR
Employees
4,935
Market Cap
588.00M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.88B | -229.42M | -10.89% |
| Dec 31, 2023 | 2.11B | 541.08M | 34.57% |
| Dec 31, 2022 | 1.57B | 318.51M | 25.55% |
| Dec 31, 2021 | 1.25B | 287.06M | 29.92% |
| Dec 31, 2020 | 959.52M | -324.64M | -25.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |